United States · FDA National Drug Code directory
Ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8875_15755a35-e29a-47c1-89ab-e6645bb3ade9
- Product NDC
- 68788-8875
- Form
- TABLET
- Composition / generic term
- Ciprofolxacin
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250519
- Source listing expiry
- 20261231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (68788-8875-0) · 68788-8875-0
- 14 TABLET in 1 BOTTLE (68788-8875-1) · 68788-8875-1
- 20 TABLET in 1 BOTTLE (68788-8875-2) · 68788-8875-2
- 30 TABLET in 1 BOTTLE (68788-8875-3) · 68788-8875-3
- 40 TABLET in 1 BOTTLE (68788-8875-4) · 68788-8875-4
- 60 TABLET in 1 BOTTLE (68788-8875-6) · 68788-8875-6
- 10 TABLET in 1 BOTTLE (68788-8875-8) · 68788-8875-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →